N.J.S.A. 30:4D-30

Maximum allowable cost per prescription drug; procedure to set and review on continuing basis

30:4D-30. Maximum allowable cost per prescription drug; procedure to set and review on continuing basis Within 6 months from the effective date of this act, the commissioner shall establish a procedure for setting and reviewing on a continuing basis the maximum allowable cost per prescription drug under the program. L.1978, c. 171, s. 7.

External source: View on Justia →

This is the verbatim text of N.J.S.A. 30:4D-30, retrieved from the New Jersey Legislature's public statute corpus. Statutes are amended periodically — for the most current version, check the external source link above. Kyzer is not a law firm and this page is not legal advice.

N.J.S.A. 30:4D-30 — Maximum allowable cost per prescription drug; procedure to set and review on continuing basis | Kyzer